The identification of the anthracycline aclarubicin as an effective cytotoxic agent for pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal types of cancer, mainly due to its delayed diagnosis and lack of effective therapeutic options. Therefore, it is imperative to find novel treatment options for PDAC. Here, we tested a series of conventional chemotherapeutics together...

Descripción completa

Detalles Bibliográficos
Autores principales: Brouwer, Thomas P., van der Zanden, Sabina Y., van der Ploeg, Manon, van Eendenburg, Jaap D.H., Bonsing, Bert A., de Miranda, Noel F.C.C., Neefjes, Jacques J., Vahrmeijer, Alexander L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Pre-Clinical Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281511/
https://www.ncbi.nlm.nih.gov/pubmed/35324522
http://dx.doi.org/10.1097/CAD.0000000000001283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281511/
https://www.ncbi.nlm.nih.gov/pubmed/35324522
http://dx.doi.org/10.1097/CAD.0000000000001283

Ejemplares similares